Inspire Pharmaceuticals have announced modifications to the clinical protocol for TIGER-2, the Company’s ongoing second Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis (C… more →
Ion channel Newswrote 1 year ago: Inspire Pharmaceuticals have announced modifications to the clinical protocol for TIGER-2, the Compa … more →
wrote 1 year ago: Inspire Pharmaceuticals have announced modifications to the clinical protocol for TIGER-2, the Compa … more →
wrote 1 year ago: Inspire’s denufosol inhalation solution has shown efficacy in Phase III trials in Cystic Fibrosis. F … more →
wrote 1 year ago: Inspire’s denufosol inhalation solution has shown efficacy in Phase III trials in Cystic Fibro … more →
wrote 1 year ago: Denufosol… the next miracle drug? Let’s hope so! There’s been a lot of buzz about … more →